PriceTargets.com logo

Alpha Cognition - ACOG Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $18.00
  • Forecasted Upside: 109.42%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$8.60 As of 09/16/2026 11:06 AM ET
▼ -0.205 (-2.33%)

This chart shows the closing price for ACOG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Alpha Cognition Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACOG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACOG

Analyst Price Target is $18.00
▲ +109.42% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Alpha Cognition in the last 3 months. The average price target is $18.00, with a high forecast of $21.00 and a low forecast of $12.00. The average price target represents a 109.42% upside from the last price of $8.60.

This chart shows the closing price for ACOG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Alpha Cognition.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/23/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/21/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/20/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2026
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/18/2026
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/17/2026
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/16/2026

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/20/2026B. Riley FinancialInitiated CoverageBuy$21.00
8/19/2026B. Riley FinancialInitiated CoverageBuy$21.00
8/17/2026HC WainwrightBoost TargetBuy ➝ Buy$18.00 ➝ $20.00
8/14/2026Craig HallumReiterated RatingBuy ➝ Buy$17.00
7/10/2026Raymond James FinancialInitiated CoverageOutperform$20.00
7/10/2026Raymond James FinancialInitiated CoverageOutperform$20.00
5/29/2026Maxim GroupInitiated CoverageBuy$12.00
5/22/2026HC WainwrightReiterated RatingBuy ➝ Buy$18.00
4/27/2026HC WainwrightReiterated RatingBuy ➝ Buy$18.00
4/17/2026Craig HallumInitiated CoverageBuy$14.00
12/19/2025HC WainwrightReiterated RatingBuy ➝ Buy$18.00
10/20/2025HC WainwrightLower TargetBuy ➝ Buy$20.00 ➝ $18.00
5/16/2025HC WainwrightReiterated RatingBuy ➝ Buy$20.00 ➝ $20.00
3/31/2025HC WainwrightReiterated RatingBuy ➝ Buy$20.00 ➝ $20.00
3/25/2025Raymond James FinancialUpgradeModerate Buy
3/18/2025HC WainwrightInitiated CoverageBuy$20.00
(Data available from 9/16/2021 forward)

News Sentiment Rating

1.18 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/18/2026
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2026
  • 4 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2026
  • 1 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/19/2026
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/18/2026
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/18/2026
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/17/2026
  • 11 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/16/2026

Current Sentiment

  • 11 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Alpha Cognition logo
Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: $8.60
Low: $8.51
High: $8.92

50 Day Range

MA: $8.83
Low: $7.89
High: $9.75

52 Week Range

Now: $8.60
Low: $4.50
High: $10.14

Volume

21,649 shs

Average Volume

76,357 shs

Market Capitalization

$187.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.32

Frequently Asked Questions

What sell-side analysts currently cover shares of Alpha Cognition?

The following Wall Street sell-side analysts have issued research reports on Alpha Cognition in the last year: B. Riley Financial, Inc., Craig Hallum, HC Wainwright, Maxim Group, Raymond James Financial, Inc., and Wall Street Zen.
View the latest analyst ratings for ACOG.

What is the current price target for Alpha Cognition?

0 Wall Street analysts have set twelve-month price targets for Alpha Cognition in the last year. Their average twelve-month price target is $18.00, suggesting a possible upside of 109.4%. B. Riley Financial, Inc. has the highest price target set, predicting ACOG will reach $21.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $12.00 for Alpha Cognition in the next year.
View the latest price targets for ACOG.

What is the current consensus analyst rating for Alpha Cognition?

Alpha Cognition currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ACOG will outperform the market and that investors should add to their positions of Alpha Cognition.
View the latest ratings for ACOG.

What other companies compete with Alpha Cognition?

Other companies that are similar to Alpha Cognition include Achieve Life Sciences, Gyre Therapeutics, Glass House Brands, Collegium Pharmaceutical and Zevra Therapeutics. Learn More about companies similar to Alpha Cognition.

How do I contact Alpha Cognition's investor relations team?

Alpha Cognition's physical mailing address is 1452 Hughes RD., Ste. 200, Grapevine, TX, 76051. The company's listed phone number is (858) 344-4375 and its investor relations email address is [email protected]. The official website for Alpha Cognition is www.alphacognition.com. Learn More about contacing Alpha Cognition investor relations.